Amgen reported $12.87B in Current Liabilities for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acceleron Pharma XLRN:US $ 49.82M 10.34M
Agios Pharmaceuticals AGIO:US $ 96.5M 2.11M
Alexion Pharmaceuticals ALXN:US $ 1426.2M 198.5M
ALKERMES ALKS:US $ 365.84M 72.42M
Amgen AMGN:US $ 12869M 1216M
Astrazeneca AZN:US $ 21513M 1206M
Biogen BIIB:US $ 3165.8M 576.4M
Biomarin Pharmaceutical BMRN:US $ 430.04M 62.51M
Bluebird Bio BLUE:US $ 206.32M 2.73M
Bristol Myers Squibb BMY:US $ 17330M 1750M
Coherus Biosciences CHRS:US $ 257.6M 111.95M
Dicerna Pharmaceuticals DRNA:US $ 182.15M 4.21M
Eli Lilly And LLY:US $ 11714.2M 767.4M
Genmab GEN:DC DK 1293M 40M
Gilead Sciences GILD:US $ 9705M 1692M
GlaxoSmithKline GSK:LN 20275M 1873M
Glaxosmithkline GSK:US $ 20275M 1873M
Intercept Pharmaceuticals ICPT:US $ 146.23M 32.84M
Johnson & Johnson JNJ:US $ 40932M 1561M
Mirati Therapeutics MRTX:US $ 77.1M 5.63M
Moderna Inc MRNA:US 8.44B 4.05B
Neurocrine Biosciences NBIX:US $ 190M 3.5M
Novartis NOVN:VX SF 30160M 2899M
Novartis NVS:US $ 30160M 2899M
Ptc Therapeutics PTCT:US $ 250.95M 26.38M
Puma Biotechnology PBYI:US $ 140.41M 26.15M
Regeneron Pharmaceuticals REGN:US $ 3217.8M 520.4M
Sarepta Therapeutics SRPT:US $ 364.74M 51.29M
Seattle Genetics SGEN:US $ 389.62M 1.48M
Takeda 4502:JP Y 1773176M 31782M
Teva Pharmaceutical TEVA:IT 12.09B 1.08B
Ultragenyx Pharmaceutical RARE:US $ 127.04M 62.56M
Vertex Pharmaceuticals VRTX:US $ 1659.88M 217.66M
YTE INCY:US $ 670.59M 39.4M